COMMUNIQUÉS West-GlobeNewswire

INNATE PHARMA : Publication of monalizumab research in the prestigious "Cell" journal

30/11/2018 - 07:01

Innate Pharma announces publication of monalizumab research in the prestigious "Cell" journal widening the horizon of immune checkpoint inhibitors Monalizumab is a first-in-class broad-spectrum immune checkpoint [...]

Innate Pharma: Publication, dans la prestigieuse revue scientifique « Cell », de travaux de recherche sur monalizumab

30/11/2018 - 07:01

Innate Pharma annonce la publication, dans lA prestigieuse revue scientifique « cell », de travaux de recherche sur monalizumab qui Élargissent l'horizon des inhibiteurs de points de contrôle immunitaire Monalizumab est [...]

Lexington Announces Q3 2018 Financial Results and Non-Brokered Private Placement

30/11/2018 - 05:46

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE [...]

Oncology Venture enters into financing agreement

30/11/2018 - 00:43

Company Announcement Oncology Venture A/S enters into a financing agreement based on the issuance of convertible notes and warrants Hoersholm, Denmark, November 30, 2018 – Oncology Venture A/S (Nasdaq First North [...]

Update -- US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US

30/11/2018 - 00:05

Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Invivoscribe is pleased to announce FDA approval of both the LeukoStrat CDx FLT3 Mutation Assay and [...]

EDAP TMS SA : EDAP Announces Expiration of Second and Final Tranche of Outstanding Warrants

29/11/2018 - 22:46

Warrants for 1.5 Million Ordinary Shares in the Form of American Depository Shares Expired on November 29, 2018 Capital Structure Now Comprised Exclusively of Common Stock LYON, France, November 29, 2018 -- EDAP TMS SA [...]

PhaseBio Reports Third Quarter 2018 Financial and Business Results

29/11/2018 - 22:30

Closed initial public offering that raised $43.0 million in net proceeds Demonstrated proof of concept for PB2452, supporting continued development for the reversal of antiplatelet activity of ticagrelor MALVERN, Pa. [...]

MPX Reports Financial Results for Its Fiscal Second Quarter of 2019

29/11/2018 - 22:30

Quarterly Revenues increased 233% to $14.7 Million TORONTO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF) today reports financial results for its [...]

Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference

29/11/2018 - 22:05

CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]

Sol-Gel Technologies Announces Participation in Upcoming Investor Conference

29/11/2018 - 22:05

NESS ZIONA, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

ChemoCentryx’s Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference

29/11/2018 - 22:05

-- Studies highlight CCX4503, a unique small molecule inhibitor of immune checkpoint molecules PD-1/PD-L1, demonstrates anti-tumor efficacy in vivo -- -- Company’s studies also show CCR4 inhibition enhances [...]

Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program

29/11/2018 - 22:01

- Achieved Phase 2 primary endpoint – over 50% of patients attained Control of Disease Activity within four weeks of starting PRN1008 - - Demonstrated sustained clinical efficacy at 12 weeks of therapy, a secondary [...]

SI-BONE, Inc. Reports Third Quarter 2018 Financial Results

29/11/2018 - 22:11

SANTA CLARA, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System [...]

Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline

29/11/2018 - 20:50

Atara has assembled core technologies and capabilities to develop next-generation and off-the-shelf, allogeneic CAR T immunotherapies, collaborating with academic leaders as well as leveraging the Company’s world-class [...]

Molecular You Receives Innovation Award for Advancing Personalized Health Through its Biomarker Health Assessments

29/11/2018 - 20:18

VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Molecular You is proud to announce it is a 2018 recipient of a TEC Edmonton Spin-Off Achievement Award for the commercialization of personalized health [...]

CORRECTING and REPLACING -- US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US

29/11/2018 - 20:16

Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Invivoscribe, Inc., please note the [...]

EssilorLuxottica - Press Release: EssilorLuxottica 2018 Combined Shareholders' Meeting

29/11/2018 - 20:01

EssilorLuxottica 2018 Combined Shareholders' Meeting Charenton-Le-Pont (November 29, 2018 - 8:00 pm) - EssilorLuxottica held its first Combined General Meeting today at the Espace Grande Arche at La Défense, chaired by [...]

EssilorLuxottica - Communiqué : Assemblée Générale Mixte EssilorLuxottica 2018

29/11/2018 - 20:01

Assemblée Générale Mixte EssilorLuxottica 2018 Charenton-le-Pont (29 novembre 2018 - 20:00) - EssilorLuxottica a tenu aujourd'hui sa première Assemblée Générale Mixte à l'Espace Grande Arche à La Défense, présidée par [...]

Constellation Pharmaceuticals to Present at BMO Healthcare Conference

29/11/2018 - 20:00

CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]